Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-07-25
1989-07-04
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544365, 544131, 544405, 514352, 546193, 546194, 546256, 546257, 546263, 546270, 546278, 546281, 546283, 546284, 546286, 546310, 546316, 546321, 546322, C07D21186, A61K 31455
Patent
active
048451134
ABSTRACT:
Compounds of formula I ##STR1## wherein R is hydrogen or lower alkyl; R.sub.1 is acetyl, benzoyl, cyano, nitro, carboxy, alkoxycarbonyl or aminocarbonyl groups; R.sub.2 is an optionally substituted aryl or hetaryl residue; R.sub.3 is a carboxy or alkoxycarbonyl group; A is a cyclopropyl group or a group of formula --CH.dbd.CH-- and R.sub.4 is a phenyl or heteroaryl group, optionally mono, di or tri-substituted, are useful in radical scavenging therapy.
REFERENCES:
patent: 4492703 (1985-01-01), Goldman et al.
patent: 4532248 (1985-07-01), Franckowiak et al.
Angelova, I. et al., Chemical Abstracts 96:162501y.
Kubo et al. Arch. Int. Pharmiodyn 272, 282-295 1984.
Franckowiak, et al "The Optical Isomers . . ." European Journal of Pharmacology, 114 (1985) pp. 223-226.
Seidel, Wolfgang, "QSAR and Molecular . . ." 2nd European Seminar & Exhi. on Computer Aided Molecular Design.
Hof, R. P. et al "Stereoselectivity at the . . ." Journal of Cardiovascular Pharmacology, 1985 pp. 689-693.
Schachtele, C. et al "Stereoselective Inhibition . . ." Naunyn-Schmiedeberg's Arch. of Phar. 1987, pp. 340-343.
Three Onoda Papers to Wayne State University.
Honn, et al, "Calcium Channel . . ." Proceedings of the Soc. for Exptl. Biology & Medicine 174, (1983) pp. 16-19.
Onoda J. et al, "Cisplatin and Nefedipine . . ." Cancer Letters 3 (1986) pp. 181-188.
Onoda, J. et al, "Calcium Channel Blockers . . ." Hemostatic Mec & Metastasis Martinus-Nighoff, The Hague, 1984 pp. 207-226.
Onoda, J. et al, "Antithrombogenic Effects of Calcium . . ." Thrombosis Research 34; 1984, pp. 367-378.
Bossert, F. et al, "4-Aryldihydropyridines, a New . . ." Angew. Chem. Int. Ed. Engl. 20.762-769 (1981).
Halliwell Faseb Journal 1, 358-364, 1987.
Halliwell Ed. "Oxygen Radicals and Tissue Injury", 1988.
McCall et al. Acta Anaesthesiologica Belgira 38, 373-379 (1987).
Del Maestro, Acta Physiol. Scan. Supp. 492, 153-168.
Simpson et al, J. Lab. Clin. Med. 110, 13-30 (1987).
Abst. from "International Conference on Oxygen, Free Radicals in Health Disease", 1988.
Frigerio Marco
Gandolfi Carmelo A.
Menta Ernesto
Spinelli Silvano
Tofanetti Odoardo
Boehringer Biochemia Robin S.p.A.
Fan Jane T.
LandOfFree
2-substituted -1,4-dihydropyridines and pharmaceutical compositi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-substituted -1,4-dihydropyridines and pharmaceutical compositi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted -1,4-dihydropyridines and pharmaceutical compositi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-852749